More cases, as well as clinical studies, are needed to confirm whether immunotherapy can be used as first‐line therapy in histiocytic sarcoma patients and whether immunotherapy is superior to other treatments in primary pulmonary histiocytic sarcoma patients with high PD‐L1 expression. Here, CD274 is linked to histiocytic sarcoma.